Volume 31, Number 2—February 2025
Online Report
Arbovirus Epidemics as Global Health Imperative, Africa, 2023
Table
Distribution of arbovirus cases in humans, Africa, 2023*
Type of arbovirus | Country | No. suspected cases | No. confirmed cases | No. deaths |
---|---|---|---|---|
Dengue | Burkina Faso | 21,4536 | 17,125 | 688 |
Mali | 5,369 | 808 | 34 | |
Ethiopia | 20,486 | 272 | 17 | |
Senegal | ND | 254 | 0 | |
Chad | 2,013 | 72 | 1 | |
Mauritius | 222 | 40 | 0 | |
São Tomé and Príncipe | ND | 31 | 22 | |
Egypt | 500 | 31 | 0 | |
Côte d'Ivoire | 85 | 22 | 0 | |
Nigeria | 72 | 14 | 0 | |
Ghana | 18 | 9 | 0 | |
Togo | ND | 8 | 1 | |
Cabo Verde | 58 | 7 | 0 | |
Angola | ND | 3 | 0 | |
Guinea | 5 | 1 | 1 | |
Niger | 148 | 0 | 0 | |
Sudan | 1,664 | ND | 7 | |
Total |
245,176 |
18,697 |
771 |
|
Yellow fever | Cameroon | 10 | 49 | 6 |
Nigeria | 1,798 | 21 | 21 | |
Congo | 374 | 15 | 2 | |
Central African Republic | 336 | 13 | 6 | |
Guinea | 262 | 3 | 4 | |
Senegal | ND | 2 | 0 | |
Côte d'Ivoire | ND | 1 | 0 | |
Gabon | 119 | ND | 0 | |
Uganda | 12 | ND | 0 | |
Total |
2,911 |
104 |
39 |
|
Chikungunya | Burkina Faso | 234 | 351 | 1 |
Senegal | ND | 338 | 0 | |
Namibia | ND | 1 | 0 | |
Mali | 4 | 1 | 0 | |
Total |
238 |
691 |
1 |
|
Crimean Congo hemorrhagic fever | Senegal | ND | 8 | 2 |
Mauritania | ND | 3 | 0 | |
Namibia | ND | 1 | 1 | |
Total |
ND |
12 |
3 |
|
Rift Valley Fever | Uganda | 20 | 27 | 4 |
Niger | ND | 1 | 1 | |
Mauritania | ND | 1 | 0 | |
Total |
20 |
29 |
5 |
|
West Nile | Tunisia | 5 | 10 | 1 |
Namibia | ND | 1 | 0 | |
Senegal | ND | 1 | 0 | |
Total |
5 |
12 |
1 |
|
Zika | Mali | ND | 22 | 0 |
Senegal | ND | 2 | 0 | |
Total | ND | 24 | 0 |
*ND, not defined
Page created: January 06, 2025
Page updated: January 31, 2025
Page reviewed: January 31, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.